<p>Restoration of miR-26b expression partially reverses the cisplatin resistance of NSCLC by targeting tafazzin</p>

Shuzhi Zang(First Affiliated Hospital of Xinxiang Medical University), Jianlian Gao(First Affiliated Hospital of Xinxiang Medical University)
OncoTargets and Therapy
September 1, 2019
Cited by 10


Related Papers